CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Sectoral Funds: Triggered To Perform Post-Pandemic

Ninad Ramdasi 0 856 Article rating: No rating

The recent pandemic engulfing the world is not the only one of its kind. There have been several such critical situations in the past and each one of them has impacted the equity markets in different ways. We take here a historical look at how such events have shaped the markets and draw conclusions about the funds that investors must invest for better returns going forward. 

Query Board

Ninad Ramdasi 0 1864 Article rating: No rating

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.

Dull start for the markets!

DSIJ Intelligence-3 0 1324 Article rating: 5.0

In early action, SGX Nifty is seen hovering around the neutral line, indicating that Indian markets may open on a flat note on Thursday. However, we expect that the stock specific action would continue and in the latter part of the day, we might witness some wild swings on account of weekly expiry.

Reliance helps Sensex jump by 742.84 points; Nifty by 205.85 points

DSIJ Intelligence 0 913 Article rating: 5.0

Termed as the largest FDI deal in India, Facebook is set to invest Rs 43,574 crore in Reliance’s subsidiary for digital services-Jio Platforms. As a result on Wednesday, the stock of Reliance Industries gained by 10.30 per cent thereby, leading Sensex to rally by 742.84 points, which is 2.42 per cent higher to be at the level of 31,379.55. Nifty also gained by 205.85 points, which is 2.29 per cent to reach at 9,187.30 level.

Man Industries resume regular operations at Anjar plant

DSIJ Intelligence 0 1897 Article rating: 3.8

Man Industries (India) Limited, one of the leading large-diameter pipe manufacturing companies announced that it has received permission from Competent Authority of Kachchh (Gujarat), allowing them to start regular operations and manufacturing activity at the company's Anjar Plant as per the guideline of Ministry of Home Affairs.

 

L&T Construction wins building & factory business contracts

DSIJ Intelligence 0 858 Article rating: 4.5

On Wednesday, Larsen & Toubro Construction announced that its buildings and factory business secured significant orders from various clients in India. Though the company did not specify the exact value of the contracts but a significant contract as per its specification ranges between Rs 1,000 crore and Rs 2,500 crore.

Bloodbath on D-Street: Sensex tumbles 1,000 points, Nifty by 280

DSIJ Intelligence 0 974 Article rating: 2.5

On Tuesday, mayhem in oil markets led to the crashing of Indian benchmark indices as Sensex plunged by 3.20 per cent which is 1,011.29 points to the level of 30,636.71 while, Nifty dipped by 3.03 per cent which is 280.40 points to be at the level of 8,981.45. In Sensex, 27 out of 30 stocks closed in red and only three stocks ended Tuesday market stir in green. Volatility index-India VIX jumped by more than four per cent to 45.34 level. 

A perfect pitch to bat out for bulls

DSIJ Intelligence-3 0 816 Article rating: 5.0

The markets showed some signs of strength in the previous session as the speed and urgency shown by multiple pharmaceuticals companies to find a resolution to COVID-19 is a good sign. Further, the optimism has been flamed after a report stated that Gilead’s drug is one of the most-watched therapies being studied for the treatment of COVID-19 patients.

RSS
First355356357358360362363364Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR